CD40LG and myeloid sarcoma: The new hyperglucosylated protein I(Glc) detected IgM and IgG in MS patient sera and discriminated between the recruited population of 126 MS patients and 112 NBDs (IgM: p < 0.0003, IgG: p < 0.0141; Supplementary Fig. 2).